• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Nvidia offers EU concessions over $54 billion Arm deal

October 6, 2021 by David Barret Leave a Comment

October 6, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Nvidia has offered concessions in a bid to secure EU antitrust approval for its $54 billion acquisition of British chip designer Arm, a European Commission filing showed on Wednesday.

The deal announced by world’s biggest maker of graphics and AI chips last year has sparked concerns in the semiconductor industry over whether Arm could remain a neutral player licensing intellectual property to customers and rivals.

The EU competition enforcer, which did not provide details of the concessions in line with its policy, set an Oct. 27 deadline for its decision.

It will now seek feedback from rivals and customers before deciding whether to accept the concessions, demand more or open a four-month long investigation.

Nvidia has said it would maintain Arm as a neutral technology supplier as it aims to allay concerns from customers such as Qualcomm Inc, Samsung Electronics Co Ltd and Apple Inc.

Arm customers Broadcom, MediaTek and Marvell are supporters of the deal.

Arm, owned by Japan’s SoftBank Group Corp, is a major player in global semiconductors. Its designs power nearly every smartphone and millions of other devices.

(Reporting by Foo Yun Chee; editing by Louise Heavens and Jason Neely)

Source Link Nvidia offers EU concessions over $54 billion Arm deal

David Barret
David Barret

Related posts:

  1. Mexico’s top court decriminalizes abortion in ‘watershed moment’
  2. SoftBank leads $680 million funding round in NFT fantasy soccer game Sorare
  3. Evergrande woes hit Japan’s toilet, air-conditioner and paint manufacturers
  4. ‘No Time to Die’ opens with $121 million in international box office sales

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Can I See Comet 3I/ATLAS From Earth During Its Closest Approach Today? Yes, Here’s How
  • The Earliest Winter Solstice Rituals Go All The Way Back To The Stone Age
  • We Were F*&@ing Right – Swearing Is Good For You And Now We Know Why
  • Why Do Wombats Have Square Poop? New Discovery Reveals How Their “Latrines” May Act Like Dating Apps
  • IFLScience The Big Questions: Answering Some Of The Biggest Scientific Mysteries Of 2025
  • Astronomers Catch Incredible First Direct Images Of Objects Colliding In Another Star System
  • Billionaire Jared Isaacman Finally Confirmed As Head Of NASA, As Agency Faces Uncertain Future
  • Something Just Crashed Into The Moon – And Astronomers Captured The Whole Event
  • These “Living Rocks” Are Among The Oldest Surviving Life And Are Champion Carbon Dioxide Absorbers
  • Ambitious Iguana “Love Island” For Near-Extinct Reptiles Becomes Epic Conservation Success Story
  • Sol 1,540: NASA Releases Video Of Perseverance Rover’s Record-Breaking Drive On Mars
  • Why Carl Sagan Was Way Ahead Of His Time And The Legacy He Left Behind
  • Why Were Pompeii Victims All Wearing Thick Woolly Cloaks In August?
  • We May Finally Know What Causes These Bizarre Bright Blue Cosmic Flashes
  • What’s The Biggest Rock In The World?
  • There Is A Very Simple Test To See If You Have Aphantasia
  • Bringing Extinct Animals To Life: Is Artificial Intelligence Helping Or Harming Palaeoart?
  • This Brilliant Map Has 3D Models Of Nearly Every Single Building In The World – All 2.75 Billion Of Them
  • These Hognose Snakes Have The Most Dramatic Defense Technique You’ve Ever Seen
  • Titan, Saturn’s Biggest Moon, Might Not Have A Secret Ocean After All
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version